研报掘金丨开源证券：维持大洋生物“买入”评级，投建PEEK及配套氟酮项目

Group 1 - The core viewpoint of the article is that the investment in the PEEK and supporting fluoroketone projects by the company opens up long-term growth potential, maintaining a "buy" rating [1] - The company plans to invest 193 million yuan to construct an annual production capacity of 2,000 tons of the specialty polymer material PEEK and key intermediates such as 4,4′-difluorobenzophenone [1] - Previously, the company had a fluorobenzene production capacity of 650 tons per year and possessed pilot test technology for fluoroketones [1] Group 2 - The PEEK project is supported by technical collaboration with well-known domestic institutions such as Dalian University of Technology [1] - Through the investment in the PEEK project, the company is expected to establish a complete industrial chain from fluorobenzene to fluoroketones to PEEK, thereby unlocking future growth opportunities [1]